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We previously reported that a mutant of Mason–Pfizer monkey virus (M-PMV), which has an amino acid substitution in the
matrix (MA) protein at position 55, MA-R55W, showed altered viral morphogenesis, reduced glycoprotein incorporation, and
loss of infectivity. In this report, we show that two additional amino acid substitutions at this site in MA, R55F and R55Y, also
result in similar altered morphogenesis, Env incorporation, and infectivity, demonstrating that these changes are not specific
for the substitution of tryptophan in place of arginine 55. Attempts to isolate second site infectious revertants from cells
transfected with the R55W mutant genome resulted only in the recovery of infectious viruses in which the codon at position
55 had reverted to one encoding arginine. In contrast, no revertants were obtained from the phenylalanine and tyrosine
mutants in which three nucleotide changes had been engineered into the arginine codon. These results confirm that the
arginine residue at position 55 is critical for intracellular targeting of M-PMV Gag molecules and support the concept that
as part of a cytoplasmic transport retention signal R55 interacts with cellular trafficking components rather than other
regions of Gag. © 2000 Academic Press
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aINTRODUCTION
Mason–Pfizer monkey virus (M-PMV) is the retrovirus
that was isolated from a breast carcinoma of a female
rhesus monkey (Chopra and Mason, 1970; Jensen et al.,
1970). Although isolated from a tumor, this virus does not
appear to be oncogenic; instead, infected macaques
suffered a severe immunosuppressive disease (Bryant et
al., 1986; Fine et al., 1975). M-PMV is characterized by the
type D morphogenesis in which immature capsids pre-
assemble within the cytoplasm of the infected cell.
The genomic organization of M-PMV consists of four
genes in the order 59 gag–pro–pol–env 39, resembling most
noncomplex retroviruses (Sonigo et al., 1986). The gag
gene products are synthesized as a polyprotein precursor,
Pr78. The precursors to the viral replicative enzymes, Gag-
Pro and Gag-Pro-Pol, are produced by ribosomal frame-
shifting at the ends of the NC and PR reading frames,
respectively. These Gag-containing precursors self-assem-
ble within the cytoplasm to form immature capsids (procap-
sids). During or shortly after virion release, the viral pro-
tease is activated and cleaves the Gag precursor polypep-
tides to yield the individual mature virion proteins, which
are arranged in the order NH2–p10(MA)–pp24/16–p12–
p27(CA)–p14(NC)–p4–COOH.
1 Present address: Center for Experimental Medicine, Institute of
edical Science, University of Tokyo, Tokyo 108-8639, Japan.
2 To whom correspondence and reprint requests should be ad-
dressed. Fax: (205) 934-1640.
533Studies in a number of systems have shown that
expression of the retroviral gag gene alone results in the
efficient assembly and release of membrane-enveloped
virus-like particles (Delchambre et al., 1989; Gheysen et
al., 1989; Haffar et al., 1990; Madisen et al., 1987; Rhee
nd Hunter, 1990b; Sommerfelt et al., 1992; Wills et al.,
1989). Thus the product of this gene has the necessary
structural information to mediate intracellular transport,
to direct assembly of the capsid shell, and to catalyze the
process of membrane extrusion known as budding. Mu-
tagenesis studies have shown that the MA and CA do-
mains of M-PMV are indispensable for virion assembly
(Rhee and Hunter, 1990b; Strambio-de-Castillia and
Hunter, 1992). Moreover, in M-PMV, a novel Gag polypro-
tein domain, p12, is also important for efficient assembly
of immature particles (Sakalian and Hunter, 1999; Som-
merfelt et al., 1992). The Gag domain, pp24/16, plays a
critical role in a late virus budding step and a PPPY
sequence within pp24/16 is indispensable for this func-
tion (Yasuda and Hunter, 1998).
Previously we reported that the introduction of random
point mutations within the MA coding domain modulated
capsid assembly, transport, and budding (Rhee and
Hunter, 1990a, 1991). An MA mutant of M-PMV, T21I/
R55W, which has two amino acid substitutions in the MA
protein at positions 21 and 55, showed altered morpho-
genesis, infectivity, and Gag precursor stability. Further
analysis showed that a single amino acid substitution at
position 55 (arginine to tryptophan) was sufficient to
convert the morphogenesis of M-PMV from that of a type
0042-6822/00 $35.00
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534 YASUDA AND HUNTERD to a type C retrovirus, which assembles capsids at the
plasma membrane. We have recently determined the
high-resolution 3D structure of M-PMV MA by nuclear
magnetic resonance (Conte et al., 1997). This structure
hows that the arginine residue at position 55 is exposed
nd positioned at the base of a loop between helices 2
nd 3 that is highly conserved in types D and B, but not
n type C, retroviral MA proteins. This loop region is
horter and adopts a different conformation in the struc-
ures of each of the type C MA proteins solved to date.
oreover, insertion of the M-PMV helix 2–3 loop into the
omologous region in MuLV Gag results in assembly in
he cytoplasm (Choi et al., 1999). Therefore, we have
peculated that this region represents a cytoplasmic
argeting/retention signal, which specifically directs Gag
recursors to an intracellular assembly site. The amino
cid substitution at position 55 of R55W may influence
he conformation of the loop and its interaction with
ellular transport proteins. In addition, since the larger
nd more hydrophobic side chain of tryptophan may
ignificantly modify the conformation of MA, other bulky
ubstitutions at this site might similarly yield altered
henotypes. In this study, we generated two additional
utations, R55F and R55Y, and analyzed their effects on
iral protein expression, protein stability, capsid assem-
ly, virion release, and infectivity. The results of these
tudies show that substitution of other residues for argi-
ine 55 yields a phenotype identical to that of R55W and
nder conditions where this single point mutation to
ryptophan reverts to wild-type (WT), no primary or sec-
nd site revertants could be detected for the phenylala-
ine and tyrosine mutations.
RESULTS
55F and R55Y mutants possess biochemical
henotypes similar to that of R55W
To determine whether the phenotypic characteristics
bserved previously for the R55W mutant are specific for
he substitution to tryptophan, we have generated two
dditional mutants, R55F and R55Y, in which arginine at
osition 55 is replaced by phenylalanine or tyrosine,
espectively. Since preliminary second site reversion ex-
eriments had suggested that the single point mutation
ithin R55W (AGG to TGG) readily reverts to wild-type,
e designed these mutants so that all three nucleotides
f the arginine codon were changed (Phe–TTC, Tyr–TAC).
n addition, since we had shown previously that the
OS-1 expression system results in very high levels of
iral protein synthesis, which can mask some mutant
henotypes (Sommerfelt et al., 1992), we established
tably transfected populations of HOS cells expressing
T and mutant genomes. Such stable lines more accu-
ately mimic the conditions of virus infection. Gag pre-
ursor stability, immature capsid assembly, and virus
elease of the R55F and R55Y mutants were compared to
d
aild-type and R55W in these stably transfected HOS
ells.
In cells expressing either WT or mutant genomes,
imilar levels of Pr78 were synthesized and then pro-
essed into mature proteins as evidenced by the appear-
nce of p27 (Fig. 1A). The CA protein (bottom band of the
FIG. 1. Pulse–chase immunoprecipitation of HOS cells that were
stably transfected with either WT or R55 mutant DNAs and were
pulse-labeled with [3H]leucine for 30 min. Immediately after the pulse
abel and after 2- and 7-h chases, virus-specific cell-associated (A) or
irion-associated (B) proteins were immunoprecipitated with anti-Pr78
r anti-M-PMV serum, respectively. The migration of the viral proteins
s indicated on the left. (C) Intracytoplasmic capsid formation: Cells
ere pulse-labeled with [3H]leucine for 30 min and then chased in
omplete medium for 30 min. Cells were lysed, and assembled capsids
ere pelleted by centrifugation. Radiolabeled Gag polyproteins in the
oluble (S) and pellet (P) fractions were immunoprecipitated with anti-
r78 serum. WT Gag precursor (Pr78) can be equally detected in both
oluble and pellet fractions, while Pr78 of all three R55 mutants was
resent predominantly in the soluble fractions.oublet) of R55F and R55Y, as well as that of R55W,
ppeared faster than that of WT following a chase of
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535MORPHOGENESIS OF TYPE D RETROVIRUSpulse-labeled cells. This is consistent with the faster rate
of virus assembly and release observed with type C
morphogenesis. Extracellular virions were released from
all three mutants, although, as previously seen with both
T21I/R55W and R55W, gp70 and gp20 were not detected
as virion-associated proteins (Fig. 1B) even though they
were readily seen in wild-type virions.
Intracellular procapsid formation is defective in the
Phe and Tyr mutants
We examined immature capsid formation in HOS
cells stably expressing the wild-type, R55W, R55F, or
R55Y mutant genomes. Cells were pulse-labeled with
[3H]leucine and then chased for 30 min. Following
ysis of the cells with 1% Triton X-100 buffer, cell
ysates were centrifuged to precipitate the assembled
apsids. Radiolabeled Gag precursors in the soluble
S) and pellet (P) fractions were immunoprecipitated
ith anti-Pr78 serum. Wild-type Gag precursors (Pr78
nd Pr95) were found at equivalent levels within the
elletable and soluble fractions of the cells (Fig. 1C).
n contrast, the R55F and R55Y mutant Gag precursors
ere found primarily in the soluble fraction. Moreover,
or these mutants p27 could be found in the soluble
raction at the end of the chase (asterisk). This is
imilar to the result obtained with the type C morpho-
enesis mutant, R55W, which assembles capsids pre-
ominantly at the plasma membrane and not in the
ytoplasm, and indicates that each of the mutant Gag
FIG. 2. Infectivity of R55 mutant virions. Virus-containing culture
medium was harvested from COS-1 cells transfected 48 h previously
with either wild-type or mutant proviruses, normalized to RT activity, and
used to infect HOS cells. Infectivity was monitored as RT activity
released over time following infection. Only wild-type (closed circles)
showed any release of RT activity. In contrast, R55W (open circles),
R55F (open squares), and R55Y (open triangles) showed no RT activity
above that detected with the uninfected cells (closed triangles), dem-
onstrating that these mutants were noninfectious.recursors has lost the ability to efficiently assemble
nto intracytoplasmic procapsids.he and Tyr substitutions for arginine 55 abrogate
irus infectivity
To determine whether the mutant viruses released
rom R55F or R55Y genome-transfected cells are infec-
ious, HOS cells were infected with an equivalent amount
f each mutant virus and assayed for reverse transcrip-
ase (RT) activity at 12 days postinfection. While wild-type
irus infected cells yielded a peak (32,000 cpm) of RT
ctivity at 12 days, no RT activity was detected in the
ulture fluids of either mutant virus-infected cells, R55F
r R55Y, indicating that these mutant viruses were non-
nfectious (Fig. 2). These results are essentially identical
o those observed for R55W, suggesting that there is no
ignificant difference in the phenotypes among R55W,
55F, and R55Y.
solation and characterization of infectious revertant
iruses from mutant transfected cells
Because the R55 mutation affects glycoprotein incor-
oration as well as the intracellular site at which capsids
re assembled, we investigated whether it might be
ossible to isolate second site revertants of the arginine
5 mutations that restored infectivity without converting
orphogenesis back to type D. COS-1 cells transfected
ith each mutant proviral DNA were trypsinized 72 h
ollowing transfection and transferred with HOS cells to a
ew plate as described under Materials and Methods.
very 3 days culture fluids were harvested to assay for
T activity. A total of eight independent experiments
ere carried out for each mutant. At 30 days after cocul-
ure, RT activity was detected in five of eight experiments
here COS cells were transfected with R55W proviral
NA (Fig. 3; C2, 3, 4, 6, and 7). In contrast, infectious
evertant viruses were not observed for either R55Y or
55F after even 54 days (data not shown).
FIG. 3. Isolation of infectious revertant viruses for R55W. Virion-
associated RT activity was measured in culture supernatants after
transfection of COS-1 cells with wild-type and R55W mutant proviral
DNAs. HOS cells were cocultured with the transfected COS-1 cells
beginning on day 3. Eight independent experiments (C1–8) were car-
ried out.
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536 YASUDA AND HUNTERThe supernatants from day 34 cocultures containing
infectious revertant viruses were used to infect HOS
cells, and then chromosomal DNA was recovered from
infected cells and used for sequence analysis. The se-
quence data revealed that all five infectious viruses, C2,
3, 4, 6, and 7, had back-reversions of the mutation at
position 55 (Trp to Arg) in the MA protein (Table 1).
Moreover, the fact that infectious virus appeared at dif-
ferent times after coculture and that two of the five
viruses had unique sequence changes in addition to the
reversion indicates that each virus arose from indepen-
dent reversion events.
DISCUSSION
We describe here that the introduction of different
single amino acid substitutions into MA residue 55 mod-
ulates capsid assembly, incorporation of the Env glyco-
protein into virions, and the infectivity of M-PMV. Each of
the mutants showed a similar impairment in the intracy-
toplasmic assembly of procapsids, yet released particles
from the cell in which the Gag precursor was cleaved
normally into the mature structural proteins. In each
case, however, the virions were severely deficient in the
Env glycoproteins, gp20 and gp70. At present, we do not
understand the molecular basis for this defect. We have
previously shown that mutant MA domains can influence
the maturational cleavage of the cytoplasmic domain of
gp22 to yield gp20 (Brody et al., 1992) and so it is
ossible that a specific protein–protein interaction nec-
ssary for Env incorporation is lacking in capsids assem-
led from the mutant precursors. Alternatively, the al-
ered assembly pathway of the R55 mutants may direct
ag to an aberrant site of budding on the membrane that
TABLE 1
Amino Acid Sequence of Revertant Viruses from R55W
Amino acid substitution in MA
12 39 41 55
Wild-type Val Lys Thr Arg
R55W Val Lys Thr Trp
(656C-T)
C2 Val Lys Thr Arg
(656T-C)
C3 Ala
(528T-C)
Glu
(608A-G)
Thr Arg
(656T-C)
C4 Val Lys Ala
(614A-G)
Arg
(656T-C)
C6 Val Lys Thr Arg
(656T-C)
C7 Val Lys Thr Arg
(656T-C)
Note. Data in parentheses indicate nucleotide substitutions.s deficient in Env. Clearly the studies presented here
how that the inability of R55 mutants to incorporate Env
t
cis not a cell line-specific defect since the previously
published studies were performed in COS cells.
Mutant virions released from cells transfected with
each R55 mutant DNA were all noninfectious. The inef-
ficient incorporation of envelope glycoprotein into virions
could be responsible for the loss of infectivity. In most
retroviruses, it is evident that the interaction between the
viral envelope glycoprotein and the MA domain of the
Gag polyprotein is required for the selective incorpora-
tion of Env during virus assembly (Dorfman et al., 1994;
reed and Martin, 1995; Gebhardt et al., 1984; Yu et al.,
1992). Previously, Freed and Martin (1996) reported that
in HIV-1 a single amino acid substitution in MA residue
12 or 30 blocked the incorporation of HIV-1 envelope
glycoproteins into virions and that truncating the cyto-
plasmic tail of gp41 could reverse this block. In addition,
the isolation and analysis of second site revertants of the
MA residue 12 mutation showed that this defect could be
compensated for by an amino acid substitution at posi-
tion 34 in MA. We reasoned, therefore, that some effects
of the R55 mutation might be compensated for by a
second site mutation in gag or env that could allow Env
ncorporation and perhaps result in infectious virus.
herefore, to test this possibility, we tried to isolate an
nfectious revertant from R55 mutant genome-transfected
ells. Surprisingly, we could obtain revertant viruses only
rom the R55W mutant that contains a single nucleotide
hange, but not from the R55F or R55Y mutants. More-
ver, the revertants were all viruses that had mutated the
ryptophan codon back to one for arginine at position 55.
o consistent changes elsewhere in MA could be found.
t least a double nucleotide substitution is required for
eversion of the phenylalanine or tyrosine substitution
nd this was clearly not favored in the reversion studies.
ore importantly, no amino acid changes in Gag or Env
rose within the 54-day period that could compensate for
he phenylalanine or tyrosine change at position 55. This
ould argue that the loss of infectivity is linked to the
hange in morphogenesis caused by the R55 mutations.
In the recently determined high-resolution 3D NMR
tructure of M-PMV MA, the arginine residue at position
5 is exposed and positioned at the base of a loop,
etween helices 2 and 3, which is highly conserved in
ype D and B retroviruses. It is likely that the amino acid
ubstitutions we have introduced at position 55 influence
he loop conformation by substituting a hydrophobic res-
due for one that is normally charged. Although we have
xplored only the substitution of different aromatic resi-
ues for the charged arginine, the fact that the R55W
nfectious revertant viruses contained only arginine at
osition 55 within MA indicates that this is the preferred
mino acid; single nucleotide changes could have also
enerated codons for serine, leucine, or glycine. Simi-
arly, single nucleotide changes in the phenylalanine or
yrosine codons would have yielded codons for isoleu-
ine, valine, cysteine, histidine, asparagine, or aspartic
t
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537MORPHOGENESIS OF TYPE D RETROVIRUSacid, but since no revertants were obtained it appears
that none of these residues can substitute for arginine.
In summary, we have shown that three different aro-
matic substitutions for MA-R55 result in mutant Gag
precursors with identical phenotypes. Reversion analy-
ses indicate that the arginine cannot be substituted by
hydrophobic, polar, or acidic residues and that the defect
in replication resulting from substitution of the arginine
cannot be readily complemented by second site muta-
tions within genes encoding the viral structural proteins.
These results are consistent with a model in which the
helix 2-helix 3 loop interacts with cellular transport pro-
teins to direct Gag precursors to an intracellular assem-
bly site (Choi et al., 1999) and that disruption of this
interaction by mutation of the arginine results in aberrant
assembly of noninfectious virions at the plasma mem-
brane.
MATERIALS AND METHODS
Oligonucleotide-directed mutagenesis
Mutagenesis was carried out using the pSelect sys-
tem (Promega), as described previously (Dubay et al.,
1992). The NarI–SacI fragment, containing the 59 region
of gag including all of the MA coding sequence through
o within the p12 domain sequence, was excised from
he wild-type M-PMV expression vector, pSHRM15 (Rhee
nd Hunter, 1990b), and subcloned into the bacterio-
hage vector, pSELECT-1. Single-stranded recombinant
NA was used as a substrate for mutagenesis. The
equences of the mutagenic oligonucleotides used are
s follows: R55F, CCTACTCTACGCCAGAATTTAATATC-
TATG; R55Y, CCTACTCTACGCCAGTATTTAATATCTATG.
After mutagenesis, each NarI–SacI fragment was ex-
cised from the replicative form of the mutant phage and
substituted for the wild-type fragment in pSHRM15. The
presence of the mutations was confirmed by dideoxy
sequencing (Sanger et al., 1977) of the double-stranded
proviral vector DNA.
Cells and transfection
COS-1 and HOS cells were maintained at 37°C in a 5%
CO2 incubator in Dulbecco’s modified Eagle’s medium
upplemented with 10% fetal bovine serum. Each mutant
NA was transfected into COS-1 cells by the calcium
hosphate method as described by Chen and Okayama
1987). Stably transfected HOS cell lines were also es-
ablished as described previously (Rhee and Hunter,
990a).
adiolabeling and immunoprecipitation of viral
roteins
COS-1 and HOS cells expressing wild-type or each
utant genome were pulse-labeled for 30 min with
3H]leucine (at 48 h posttransfection for COS cells) andhased for the indicated period in complete medium.
ells were lysed and then immunoprecipitated with a
abbit anti-Pr78gag antiserum as described previously
Bradac and Hunter, 1984; Sakalian et al., 1996). Radio-
abeled virus particles, which were released from the
hased cells into the culture medium, were pelleted by
entrifugation for 15 min at 80,000 rpm in a Beckman
LA100.3 rotor at 4°C. The pellet was lysed and then
mmunoprecipitated with goat anti-M-PMV antiserum
Rhee and Hunter, 1990a). Immunoprecipitated proteins
ere separated on a 12% resolving gel by SDS–PAGE.
etection of intracytoplasmic procapsid assembly
To analyze procapsid formation in mutant expressing
ells, Gag polyproteins were fractionated into free and
apsid-associated forms as described previously (Rhee
nd Hunter, 1990a). Each fraction was immunoprecipi-
ated with rabbit anti-Pr78gag antiserum and analyzed by
SDS–PAGE.
Infectivity assays
Infectivity of the mutant virions was determined by
measuring the spread of RT-containing virus through the
inoculated HOS cell culture at various times postinfec-
tion. Culture fluids were harvested for 48 h from COS-1
cells that had been transfected with either wild-type or
mutant DNA. After clarification by centrifugation, the level
of RT activity in the medium was measured and an
equivalent amount of RT-containing medium was used to
infect HOS cells in the presence of 4.0 mg/ml of poly-
brene (Sigma). Culture fluids were harvested on days 3,
6, 9, and 12 postinfection and assayed for RT activity as
described previously (Yasuda and Hunter, 1998).
Isolation of infectious revertants
COS-1 cells transfected with each mutant DNA were
trypsinized 72 h following transfection and transferred to
a new plate for coculture with HOS cells at a ratio of 1:4.
Every 3 days, culture fluids were harvested to assay for
RT activity and cells were passaged. Infectious revertant
viruses from coculture were inoculated onto fresh plates
of HOS cells and following the establishment of the new
infection chromosomal DNA was recovered from the
cells. The gag gene fragment containing the MA and
pp24/16 regions was amplified by PCR of chromosomal
DNA using oligonucleotides, YG1 (TTCCTACTGTT-
GATCCC; position 316–332 in pSHRM15) and YG3 (TAGT-
GCCTGGTGTAACTC; 1228–1211). The resulting PCR frag-
ments were inserted into the pCRII vector using the TA
cloning kit (Invitrogen) and were sequenced as de-
scribed above.
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